VRAP-Heart - Virtual Reality Assisted Patient Empowerment for Interventions in Structural Heart Disease

Recruiting N/A Interventional Study
Severe Aortic Valve Stenosis
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
300 (estimated)
Sponsor
Heinrich-Heine University, Duesseldorf · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

This prospective, randomized-controlled multicenter study investigates whether virtual reality-assisted patient education in patients undergoing transfemoral transcatheter aortic valve implantation (TAVI) can improve patient understanding and simulative orientation, thereby reducing postinterventional complications, resulting in significantly shorter length of stay.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * High-grade aortic valve stenosis * Indication for elective transfemoral transcatheter aortic valve implantation under analgesia (TAVI) * Existing heart center decision * Age ≥ 18 years * Signed informed consent form Exclusion Criteria: * Surgery planned under general anesthe…
Contacts

Christian Jung, Prof MD PhD

+49 211 81

christian.jung@med.uni-duesseldorf.de

CONTACT

Raphael Bruno, MD

+49 211 81

raphael.bruno@med.uni-duesseldorf.de

CONTACT